BIO-RAD LABORATORIES INC
NYSE: BIO (Bio-Rad Laboratories, Inc.)
Last update: 11 hours ago282.44
-2.23 (-0.78%)
| Previous Close | 284.67 |
| Open | 284.61 |
| Volume | 213,947 |
| Avg. Volume (3M) | 377,880 |
| Market Cap | 7,558,545,920 |
| Price / Earnings (TTM) | 46.92 |
| Price / Earnings (Forward) | 31.95 |
| Price / Sales | 2.95 |
| Price / Book | 1.10 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2026 |
| Profit Margin | -85.16% |
| Operating Margin (TTM) | 9.72% |
| Diluted EPS (TTM) | -76.53 |
| Quarterly Revenue Growth (YOY) | -4.20% |
| Quarterly Earnings Growth (YOY) | -83.30% |
| Total Debt/Equity (MRQ) | 20.50% |
| Current Ratio (MRQ) | 5.99 |
| Operating Cash Flow (TTM) | 515.30 M |
| Levered Free Cash Flow (TTM) | 250.23 M |
| Return on Assets (TTM) | 1.55% |
| Return on Equity (TTM) | -27.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Bio-Rad Laboratories, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 1.5 |
| Average | -1.00 |
|
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 16.14% |
| % Held by Institutions | 93.04% |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |